NON-PROLIFERATIVE DIABETIC RETINOPATHY (NPDR)
Clinical trials for NON-PROLIFERATIVE DIABETIC RETINOPATHY (NPDR) explained in plain language.
Never miss a new study
Get alerted when new NON-PROLIFERATIVE DIABETIC RETINOPATHY (NPDR) trials appear
Sign up with your email to follow new studies for NON-PROLIFERATIVE DIABETIC RETINOPATHY (NPDR), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a ginkgo pill save your eyesight? new trial aims to find out
Disease control Not yet recruitingThis study tests whether a ginkgo biloba extract (EGb761) can slow or prevent diabetic retinopathy, an eye disease caused by diabetes. About 200 adults with long-standing diabetes will take either ginkgo or standard treatment for 2 years. Researchers will measure changes in eye b…
Matched conditions: NON-PROLIFERATIVE DIABETIC RETINOPATHY (NPDR)
Phase: PHASE2 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New eye drops aim to slow diabetic vision damage
Disease control Not yet recruitingThis early study tests NPDR-01 eye drops in 10 adults with non-proliferative diabetic retinopathy, a common eye complication of diabetes. Participants will use one drop daily for 6 months to see if it reduces tiny retinal bleeds (microaneurysms) and slows disease progression. The…
Matched conditions: NON-PROLIFERATIVE DIABETIC RETINOPATHY (NPDR)
Phase: EARLY_PHASE1 • Sponsor: Sichuan Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC